BSN-AS1

Across TCGA pan-cancer cohorts, BSN-AS1 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated BSN-AS1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher BSN-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated BSN-AS1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and MESO show a favorable association.

LUAD, OV, and MESO are the cancer types where BSN-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.793	0.644	.008	48	view →
OV	DFS	Median	III,IV	0.480	0.568	.012	44	view →
MESO	DFS	Tertile	III,IV	0.499	0.216	.008	33	view →
ESCA	OS	Quartile	IV	0.127	0.601	.017	18	view →
BLCA	OS	Tertile	III,IV	0.623	0.360	.040	12	view →
SKCM	DFS	Tertile	IV	0.714	0.231	.020	12	view →
COAD	OS	Tertile	III,IV	0.396	0.704	.026	12	view →
LAML	DFS	Median	All	0.575	0.350	.014	10	view →
ACC	DFS	Tertile	II,III,IV	0.164	0.600	.042	9	view →
KIRC	DFS	Tertile	All	0.749	0.881	.019	6	view →
CESC	DFS	Tertile	III,IV	1.000	0.677	.037	6	view →
LGG	OS	Median	All	0.561	0.394	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

BSN-AS1–LUAD (DFS)

Open the LUAD breakdown →